Dr. Pamela Samson, M.D., MPHS
Claim this profileWashington University School of Medicine
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
30 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Pamela Samson, M.D., MPHS is currently running
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
CT-Guided Stereotactic Radiotherapy
for Lung Cancer
This study will evaluate the impact of CT-guided adaptive stereotactic radiotherapy (CT-STAR) to central and ultra-central early-stage non-small cell lung cancers on grade 3 or greater toxicity. Online adaptive radiation therapy was until recently only done clinically on an integrated MRI-guided system, but recently, Varian Medical Systems has created a CT-guided radiotherapy machine capable of online adaptive radiotherapy (ETHOS). The vast majority of stereotactic body radiotherapy (SBRT) for early-stage lung cancers is performed on a CT-guided machine rather than an MRI-guided machine, necessitating the evaluation of adaptive radiotherapy using ETHOS in this population. Historically, the non-adaptive, stereotactic treatment of central and ultra-central thoracic disease has been associated with unacceptable rates of grade 3+ toxicity. This has resulted in widespread adoption of a hypofractionated, less ablative 8-15 day treatment courses, with a baseline, one-year grade 3+ toxicity rate of 20%. Use of CT-STAR with daily, CT-guided plan adaptation to carefully spare adjacent organs-at-risk (OAR) in this setting may enable safe delivery of a shorter (5 fraction) and more ablative radiotherapy course.
Recruiting1 award N/A11 criteria
More about Pamela Samson, M.D., MPHS
Clinical Trial Related5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Pamela Samson, M.D., MPHS has experience with
- Durvalumab
- Paclitaxel
- Radiation Therapy
- One Fraction Stereotactic Body Radiotherapy
- Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR)
- Carboplatin AUC
Breakdown of trials Pamela Samson, M.D., MPHS has run
Lung Cancer
Non-Small Cell Lung Cancer
Stomach Cancer
Brain Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pamela Samson, M.D., MPHS specialize in?
Pamela Samson, M.D., MPHS focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Pamela Samson, M.D., MPHS currently recruiting for clinical trials?
Yes, Pamela Samson, M.D., MPHS is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Pamela Samson, M.D., MPHS has studied deeply?
Yes, Pamela Samson, M.D., MPHS has studied treatments such as Durvalumab, Paclitaxel, Radiation therapy.
What is the best way to schedule an appointment with Pamela Samson, M.D., MPHS?
Apply for one of the trials that Pamela Samson, M.D., MPHS is conducting.
What is the office address of Pamela Samson, M.D., MPHS?
The office of Pamela Samson, M.D., MPHS is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.